The Endpoints Slack interview: Cellino CEO Nabiha Saklayen on cell therapy’s future, Elon Musk and time travel

Nabiha Saklayen founded Cellino Biotech just as she was finishing her PhD in physics at Harvard in 2017, while she was still in her 20s.

The startup is trying to create automated ways to produce cell therapies and raised an $80 million Series A round in 2022 to get to work. Endpoints News caught up with Saklayen on how that effort is going, as well as her thoughts on Elon Musk, mission control at Cellino, and even time travel.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

DOJ plans to take mifepristone challenge to the Supreme Court

The US Department of Justice is heading to the Supreme Court with a challenge to the latest court-imposed restrictions around the abortion drug mifepristone. The

August 18, 2023

Sanofi’s $17bn sale of Opella to US investors advances following government deal – Pharmaceutical Technology

Opella manufactures Doliprane, a popular painkiller in France. Image credit: Shutterstock / Marc Bruxelle. Sanofi has entered exclusive talks with US private equity company Clayton

October 21, 2024

Researchers discover a noninvasive, low-cost test to detect oral cancer

Oral cancers and precancerous mouth lesions are considered especially difficult to diagnose early and accurately.

March 4, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.